Adjuvant alpha-interferon treatment after resection of hepatocellular carcinoma in HCV related cirrhosis: a randomized trial on prevention of cancer recurrence.

Trial Profile

Adjuvant alpha-interferon treatment after resection of hepatocellular carcinoma in HCV related cirrhosis: a randomized trial on prevention of cancer recurrence.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2009

At a glance

  • Drugs Interferon alpha-2b (Primary) ; Interferon alpha
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top